NCDDGNational Cooperative Drug Discovery Groups
References in periodicals archive ?
Garth Powis, Director of Basic Research at the Arizona Cancer Center, and the NCDDG grant's Project Leader.
The NCI funding will be used to establish an NCDDG collaboration between Geron, Memorial Sloan-Kettering Cancer Center (MSKCC) and its affiliate--Sloan-Kettering Institute for Cancer Research, and the NCI, with the goal of identifying and developing a telomerase inhibitor for treating a broad spectrum of human malignancies.
Geron's role in the NCDDG will be to discover and optimize new chemical entities directed against telomerase.